Serial Number | 97021067 |
Word Mark | SUZHOU FUSE BIOSCIENCES |
Filing Date | Friday, September 10, 2021 |
Status | 602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE |
Status Date | Tuesday, January 10, 2023 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Therapeutic agents and preparations consisting primarily of biochemicals, immunoglobulin, antigen-binding fragments and cytokines for use in cancer therapies or immunotherapies; preparations and substances for medical purposes; immunotherapies and therapeutic agents, preparations and substances in the field of locoregionally active cytokines for medical purposes; immunotherapies and therapeutic agents, preparations and substances in the field of oncology for medical purposes |
Goods and Services | Scientific research and development in the field of therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines; medical and scientific research and development for agents, preparations, products and technology in the field of immunocytokines; providing medical and scientific research information field of therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines; scientific investigations for medical purposes; medical research; providing scientific and medical research information and analysis relating therapeutic biochemicals, immunoglobulins, antigen-binding fragments and cytokines, engineered cell therapies and immunotherapy, oncology and immunocytokines for medical purposes; testing, research, design and development services in the field of biochemicals for scientific and medical research purposes; research, design and development of assays for measuring, monitoring, testing and analyzing antibody binding, therapeutic treatments and patient recovery, and for identifying candidate patient populations for specific therapeutic treatments; providing technical support and consultation services relating to antibody selection and use, namely, providing technical scientific research consultation services |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, October 19, 2021 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Tuesday, October 19, 2021 |
Primary Code | 042 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Suzhou Fuse Biosciences Limited |
Party Type | 10 - Original Applicant |
Legal Entity Type | 99 - Other |
Address | Jiangsu 215128 CN |
Event Date | Event Description |
Wednesday, December 13, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Wednesday, December 13, 2023 | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS |
Wednesday, December 13, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Wednesday, December 13, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Tuesday, January 10, 2023 | ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND |
Tuesday, January 10, 2023 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
Tuesday, January 10, 2023 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
Monday, June 27, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Monday, June 27, 2022 | NON-FINAL ACTION E-MAILED |
Monday, June 27, 2022 | NON-FINAL ACTION WRITTEN |
Wednesday, June 15, 2022 | ASSIGNED TO EXAMINER |
Tuesday, October 19, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Tuesday, September 14, 2021 | NEW APPLICATION ENTERED |